Anti-thrombotic effect of ONO-8809, a novel TXA2/PG endoperoxide receptor antagonist.
Wakitani
K
K
Minase Research Institute, Ono Pharmaceutical Co., Ltd., Osaka, Japan.
Matsumoto
R
R
Imawaka
H
H
Kamanaka
Y
Y
Naka
M
M
Hamanaka
N
N
Okegawa
T
T
Kawasaki
A
A
D000818:Animals; D001643:Bridged Bicyclo Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D003328:Coronary Thrombosis / Q000517:prevention & control*; D003645:Death, Sudden / Q000209:etiology; D004195:Disease Models, Animal; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography / Q000187:drug effects; D005229:Fatty Acids, Monounsaturated / Q000494:pharmacology* / Q000627:therapeutic use; D005343:Fibrinolytic Agents; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D015394:Molecular Structure; D011355:Prodrugs / Q000494:pharmacology* / Q000627:therapeutic use; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors*; D017482:Receptors, Thromboxane
D001643:Bridged Bicyclo Compounds; D005229:Fatty Acids, Monounsaturated; D005343:Fibrinolytic Agents; D011355:Prodrugs; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; C067427:ONO 8809